Releaf · hybrid-indica

Releaf T20 Critical Cure

Bred by Releaf.

THC18–22% THCCBD3.8–4.2% CBD
Releaf T20 Critical Cure — botanical reference image
Educational reference. Not medical advice. Medical cannabis is a prescription-only medicine in the UK — consult a specialist clinician.

History & Producer

Origin

Pharmacy-grade dried flower produced by Releaf. Lineage: Critical Kush × CBD. Available to UK patients via private clinics.

Genetics

Lineage

Critical Kush × CBD

Indica 70%Sativa 30%

Cannabinoid & Production Profile

Specifications

THC
18–22% THC
CBD
3.8–4.2% CBD
Classification
hybrid-indica
Cultivation
Irradiation

More from Releaf

Same Producer